CMAS is up-regulated in seven of the eight cancer types (except for COAD); and NEU1 tends to correlate with CMAS throughout the major portion of a cancer progression for all cancer types, except for the last stage(s), where the two curves may diverge or converge for some cancer types, as detailed in Figure 1. The gene discussed is NEU1; the disease is cancer.